Jiangsu Yuyue Medical Equipment & Supply Future Growth
Future criteria checks 2/6
Jiangsu Yuyue Medical Equipment & Supply is forecast to grow earnings and revenue by 18.7% and 16% per annum respectively. EPS is expected to grow by 18.6% per annum. Return on equity is forecast to be 16% in 3 years.
Key information
18.7%
Earnings growth rate
18.6%
EPS growth rate
Medical Equipment earnings growth | 26.1% |
Revenue growth rate | 16.0% |
Future return on equity | 16.0% |
Analyst coverage | Good |
Last updated | 05 Nov 2024 |
Recent future growth updates
Recent updates
Little Excitement Around Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.'s (SZSE:002223) Earnings
Dec 09Why Jiangsu Yuyue Medical Equipment & Supply's (SZSE:002223) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 03Here's Why Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Can Manage Its Debt Responsibly
Sep 13Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Has More To Do To Multiply In Value Going Forward
Aug 14Here's Why Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Has Caught The Eye Of Investors
Jul 29Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Is Paying Out A Larger Dividend Than Last Year
May 26Is Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) A Risky Investment?
May 21Jiangsu Yuyue Medical Equipment & Supply's (SZSE:002223) Profits May Not Reveal Underlying Issues
May 03Earnings Report: Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Missed Revenue Estimates By 7.0%
Apr 30The Return Trends At Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) Look Promising
Apr 22Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.'s (SZSE:002223) Shares Lagging The Market But So Is The Business
Apr 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 10,776 | 2,777 | N/A | 2,773 | 10 |
12/31/2025 | 9,422 | 2,386 | N/A | 2,334 | 11 |
12/31/2024 | 8,248 | 2,082 | N/A | 1,794 | 11 |
9/30/2024 | 7,337 | 1,737 | 1,665 | 1,763 | N/A |
6/30/2024 | 7,299 | 2,022 | 1,539 | 1,641 | N/A |
3/31/2024 | 7,423 | 2,242 | 1,706 | 1,818 | N/A |
12/31/2023 | 7,972 | 2,396 | 1,994 | 2,127 | N/A |
9/30/2023 | 8,648 | 2,650 | 2,602 | 2,885 | N/A |
6/30/2023 | 8,529 | 2,302 | 2,501 | 2,877 | N/A |
3/31/2023 | 7,983 | 1,845 | 2,335 | 2,708 | N/A |
1/1/2023 | 7,102 | 1,595 | 1,926 | 2,305 | N/A |
9/30/2022 | 6,700 | 1,266 | 1,121 | 1,280 | N/A |
6/30/2022 | 6,854 | 1,307 | 1,224 | 1,328 | N/A |
3/31/2022 | 7,054 | 1,487 | 1,297 | 1,441 | N/A |
1/1/2022 | 6,894 | 1,482 | 917 | 1,201 | N/A |
9/30/2021 | 7,188 | 1,600 | 578 | 1,365 | N/A |
6/30/2021 | 6,898 | 1,603 | 491 | 1,255 | N/A |
3/31/2021 | 6,996 | 1,836 | 1,379 | 2,053 | N/A |
12/31/2020 | 6,726 | 1,759 | 2,152 | 2,831 | N/A |
9/30/2020 | 5,928 | 1,550 | 2,770 | 3,033 | N/A |
6/30/2020 | 5,555 | 1,339 | 2,574 | 2,859 | N/A |
3/31/2020 | 4,826 | 889 | 1,230 | 1,684 | N/A |
12/31/2019 | 4,636 | 753 | 174 | 614 | N/A |
9/30/2019 | 4,559 | 812 | 128 | 559 | N/A |
6/30/2019 | 4,462 | 791 | 219 | 732 | N/A |
3/31/2019 | 4,343 | 760 | 176 | 653 | N/A |
12/31/2018 | 4,183 | 727 | 409 | 798 | N/A |
9/30/2018 | 4,029 | 693 | 70 | 525 | N/A |
6/30/2018 | 3,903 | 664 | N/A | 374 | N/A |
3/31/2018 | 3,681 | 620 | N/A | 265 | N/A |
12/31/2017 | 3,542 | 592 | N/A | 242 | N/A |
9/30/2017 | 3,333 | 595 | N/A | 355 | N/A |
6/30/2017 | 3,073 | 567 | N/A | 455 | N/A |
3/31/2017 | 2,808 | 544 | N/A | 463 | N/A |
12/31/2016 | 2,640 | 500 | N/A | 674 | N/A |
9/30/2016 | 2,470 | 464 | N/A | 657 | N/A |
6/30/2016 | 2,440 | 444 | N/A | 632 | N/A |
3/31/2016 | 2,295 | 398 | N/A | 659 | N/A |
12/31/2015 | 2,104 | 364 | N/A | 543 | N/A |
9/30/2015 | 1,951 | 377 | N/A | 440 | N/A |
6/30/2015 | 1,838 | 357 | N/A | 338 | N/A |
3/31/2015 | 1,754 | 311 | N/A | 272 | N/A |
12/31/2014 | 1,682 | 297 | N/A | 206 | N/A |
9/30/2014 | 1,658 | 300 | N/A | 144 | N/A |
6/30/2014 | 1,614 | 294 | N/A | 123 | N/A |
3/31/2014 | 1,526 | 276 | N/A | 139 | N/A |
12/31/2013 | 1,424 | 258 | N/A | 124 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 002223's forecast earnings growth (18.7% per year) is above the savings rate (2.8%).
Earnings vs Market: 002223's earnings (18.7% per year) are forecast to grow slower than the CN market (25.7% per year).
High Growth Earnings: 002223's earnings are forecast to grow, but not significantly.
Revenue vs Market: 002223's revenue (16% per year) is forecast to grow faster than the CN market (13.7% per year).
High Growth Revenue: 002223's revenue (16% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 002223's Return on Equity is forecast to be low in 3 years time (16%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 09:14 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. is covered by 33 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yin Zhang | BOCI Research Ltd. |
Lei Zhang | Bohai Securities Co., Ltd. |
Shuchang Liu | Changjiang Securities Co. LTD. |